Tikva Allocell is a cell therapy company focused on a Second Generation Allogeneic EBV-Specific T cell (ALLO EBVST) platform to target difficult-to-treat cancers.

At Tikva Allocell, our mission is to develop safe, effective, readily available and affordable “off-the-shelf” T cell therapies by leveraging excellent safety profile of ALLO EBVST and proprietary technologies that enhance the T cell's performance to treat cancer.

Biotechnology

Life Sciences

Therapeutics

Tikva Allocell Pte Ltd

Tikva Allocell Pte Ltd's headquarters in Biopolis, Singapore

Description

People

Jobs